Oncosil Medical Ltd
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorp… Read more
Oncosil Medical Ltd (OSL) - Total Assets
Latest total assets as of December 2025: AU$7.13 Million AUD
Based on the latest financial reports, Oncosil Medical Ltd (OSL) holds total assets worth AU$7.13 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oncosil Medical Ltd - Total Assets Trend (2005–2025)
This chart illustrates how Oncosil Medical Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oncosil Medical Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Oncosil Medical Ltd's total assets of AU$7.13 Million consist of 94.1% current assets and 5.9% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 71.5% |
| Accounts Receivable | AU$1.20 Million | 16.9% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$424.29K | 5.9% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Oncosil Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oncosil Medical Ltd's current assets represent 94.1% of total assets in 2025, a decrease from 97.0% in 2005.
- Cash Position: Cash and equivalents constituted 71.5% of total assets in 2025, down from 93.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 16.9% of total assets.
Oncosil Medical Ltd Competitors by Total Assets
Key competitors of Oncosil Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Oncosil Medical Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oncosil Medical Ltd generates 0.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oncosil Medical Ltd is currently not profitable relative to its asset base.
Oncosil Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.05 | 3.81 | 9.47 |
| Quick Ratio | 2.05 | 3.81 | 9.47 |
| Cash Ratio | 0.00 | 2.92 | 9.02 |
| Working Capital | AU$3.45 Million | AU$ 8.17 Million | AU$ 16.88 Million |
Oncosil Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Oncosil Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.51 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | 6.4% |
| Total Assets | AU$7.15 Million |
| Market Capitalization | $5.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oncosil Medical Ltd's assets below their book value (0.76 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Oncosil Medical Ltd's assets grew by 6.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Oncosil Medical Ltd (2005–2025)
The table below shows the annual total assets of Oncosil Medical Ltd from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$7.15 Million | +6.40% |
| 2024-06-30 | AU$6.72 Million | -41.45% |
| 2023-06-30 | AU$11.47 Million | -12.21% |
| 2022-06-30 | AU$13.07 Million | -7.64% |
| 2021-06-30 | AU$14.15 Million | -41.19% |
| 2020-06-30 | AU$24.06 Million | +106.20% |
| 2019-06-30 | AU$11.67 Million | -41.31% |
| 2018-06-30 | AU$19.88 Million | +68.42% |
| 2017-06-30 | AU$11.80 Million | -25.74% |
| 2016-06-30 | AU$15.90 Million | +114.62% |
| 2015-06-30 | AU$7.41 Million | -23.13% |
| 2014-06-30 | AU$9.64 Million | +54.34% |
| 2013-06-30 | AU$6.24 Million | +147.41% |
| 2012-06-30 | AU$2.52 Million | -16.71% |
| 2011-06-30 | AU$3.03 Million | +2.41% |
| 2010-06-30 | AU$2.96 Million | -43.41% |
| 2009-06-30 | AU$5.23 Million | -15.23% |
| 2008-06-30 | AU$6.17 Million | -11.92% |
| 2007-06-30 | AU$7.00 Million | -14.45% |
| 2006-06-30 | AU$8.18 Million | +764.63% |
| 2005-06-30 | AU$946.59K | -- |